Companies / CytomX Therapeutics, Inc. / Activity
Activity — CytomX Therapeutics, Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $2.49M | +663K | 663,038 0.30% of shares | low |
| Q1 2026 as of | DAFNA Capital Management LLC 13F manager | New | Common stock | $1.08M | +230K | 230,000 0.11% of shares | low |
| Q1 2026 as of | ALPS Advisors, Inc. 13F manager | New | Common stock | $497.4K | +106K | 105,820 0.05% of shares | low |
| Q1 2026 as of | California State Teachers Retirement System 13F manager | New | Common stock | $415.4K | +88K | 88,379 0.04% of shares | low |
| Q1 2026 as of | Zurcher Kantonalbank (Zurich Cantonalbank) 13F manager | New | Common stock | $225.5K | +48K | 47,988 0.02% of shares | low |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | New | Common stock | $219.7K | +47K | 46,700 0.02% of shares | low |
| Q2 2026 as of | Arizona State Retirement System 13F manager | New | Common stock | $167.8K | +45K | 44,737 0.02% of shares | low |
| Q1 2026 as of | Gabelli Funds LLC 13F manager | New | Common stock | $155.1K | +33K | 33,000 0.02% of shares | low |
| Q3 2025 as of | Sanctuary Advisors, LLC 13F manager | New | Common stock | $110.5K | +35K | 34,634 0.02% of shares | low |
| Q2 2022 as of | Leonteq Securities AG 13F manager | New | Common stock | $11.0K | +6K | 6,000 <0.01% of shares | low |
| Q2 2026 as of | SG Americas Securities, LLC 13F manager | New | Common stock | $138 | +37K | 36,863 0.02% of shares | low |
| Q1 2025 as of | Barclays PLC 13F manager | New | Common stock | $1 | +2 | 2 <0.01% of shares | low |